v3.26.3
Equity (Details Narrative) - USD ($)
12 Months Ended
May 22, 2026
Nov. 12, 2025
Oct. 27, 2025
Aug. 29, 2024
Jun. 18, 2024
May 12, 2022
Jun. 30, 2026
Jun. 30, 2025
May 13, 2022
May 05, 2021
Subsidiary, Sale of Stock [Line Items]                    
Common stock, shares authorized             980,000,000 980,000,000    
Preferred stock shares authorized             20,000,000 20,000,000    
Preferred stock, par value             $ 0.001 $ 0.001    
Placement agent fees and other direct offering costs             $ (0) $ 325,000    
Common stock issued and treasury shares held             168,542      
Common stock, shares outstanding             167,196 14,518    
Common stock, shares outstanding             167,196 14,518    
Preferred stock, shares issued             0 0    
Preferred stock, shares outstanding             0 0    
Stock compensation expense             $ 792,375 $ (12,998)    
Equity Incentive Plan [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Issuance of shares                   50,000,000
Consultants [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Number of shares issued for services             5,231      
Vassily [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Exercise price                 $ 2,419.2  
Cash performance bonus           $ 60,000        
Monte Carlo [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Volatility rate           95.65%        
Expected term           10 years        
Risk free rate of return           2.93%        
Dividend yield           0.00%        
Convertible Notes [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Debt converted, shares issued             148,234      
Conversion converted instrument amount             $ 9,150,119      
Exercise price             $ 61.73      
Common Stock [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Shares repurchased during period             1,346      
Aggregate cost of repurchased shares             $ 41,755      
Common Stock [Member] | RSU Vested And Converted [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Stock shares issued               132    
Conversion of stock, shares to be issued             57      
Restricted Stock Units (RSUs) [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Vested RSUs             1,619      
Stock compensation expense             $ 866,667 $ 93,455    
Unvested number of RSUs             868 7    
Unamortized expense             $ 33,333 $ 8,333    
Restricted Stock Units (RSUs) [Member] | RSU Vested And Converted [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Stock converted, shares converted               189    
Restricted Stock Units (RSUs) [Member] | Chief Executive Officer [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Granted an additional shares of RSUs, value   $ 800,000                
Granted an additional shares of RSUs   1,127                
Closing price   $ 709.85                
Restricted Stock Units (RSUs) [Member] | Director [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Granted an additional shares of RSUs             2,480 41    
Restricted Stock Units (RSUs) [Member] | Common Stock [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Vested RSUs             554      
Round Up Shares [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Number of shares issued connection with reverse stock split 5   5              
Option Grants [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Stock compensation expense             $ 472,343 $ 468,778    
Unrecognized compensation cost             0      
Option Grants [Member] | Vassily [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Options, grants in period           153        
Option Grants [Member] | Chenlong Tan [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Options, grants in period           1,389        
Stock Options 2024 [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Volatility rate       101.00%            
Expected term       5 years 8 months 15 days            
Risk free rate of return       3.66%            
Stock compensation expense             398,047 $ 362,325    
Dividend yield       0.00%            
Unrecognized compensation cost             $ 500,000      
Exercise price per share       $ 3,088.8            
Stock options term       10 years            
Stock options vested       14     180 165    
Stock options to be vested             15      
Fair value of options granted       $ 1,220,000            
Stock Options 2024 [Member] | Chenlong Tan [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Stock options granted       556            
Pre Reverse Split [Member] | Monte Carlo [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Share price           $ 1.12        
Pre Reverse Split [Member] | Stock Options 2024 [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Share price       $ 1.30            
Share price       1.43            
Post Reverse Split [Member] | Monte Carlo [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Share price           $ 2,419.20        
Post Reverse Split [Member] | Stock Options 2024 [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Share price       2,808.00            
Share price       $ 3,088.80            
Private Placement Offering [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Warrants fair value         $ 3,100,000          
Relative fair value after allocation of shares         $ 1,700,000          
Volatility rate         104.00%          
Expected term         5 years          
Risk free rate of return         4.24%          
Private Placement Offering [Member] | Pre Reverse Split [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Warrant exercise price         $ 2.40          
Share price         2.00          
Private Placement Offering [Member] | Post Reverse Split [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Warrant exercise price         5,184.00          
Share price         $ 4,320.00          
Share Cancellation [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Number of share cancellation         18,056          
Additional paid-in capital         $ 542          
Registered Direct Offering [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Stock issued new, shares         965          
Warrants issued         965          
Gross proceeds from the sale of equity         $ 5,000,002          
Warrants outstanding term         5 years          
Warrant exercise price         $ 5,184.0          
Placement agent fees and other direct offering costs         $ 456,913          
Proceeds from the sale of equity         $ 4,543,089